Finding transcriptomics biomarkers for in vivo identification of (non-)genotoxic carcinogens using wild-type and Xpa/p53 mutant mouse models-Reference-Cited by-同舟云学术

Finding transcriptomics biomarkers for in vivo identification of (non-)genotoxic carcinogens using wild-type and Xpa/p53 mutant mouse models

Published:2009-08-20 Issue:10 Volume:30 Page:1805-1812
ISSN:1460-2180
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Jonker Martijs J.,Bruning Oskar,van Iterson Maarten,Schaap Mirjam M.,van der Hoeven Tessa V.,Vrieling Harry,Beems Rudolf B.,de Vries Annemieke,van Steeg Harry,Breit Timo M.,Luijten Mirjam

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/30/10/1805/17286622/bgp190.pdf

Reference32 articles.

1. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH);Lilienblum;Arch. Toxicol.,2008

2. Statistical methods in cancer research: the design and analysis of long-term animal experiments;Gart;IARC Sci. Publ.,1986

3. Long-term and short-term assays for carcinogens: a critical appraisal;Montesano;IARC Sci. Publ.,1986

4. Association of tumor development with increased cellular proliferation and transgene overexpression, but not c-Ha-ras mutations, in v-Ha-ras transgenic Tg.AC mice;Hansen;Carcinogenesis,1996

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-term in vivo testing to discriminate genotoxic carcinogens from non-genotoxic carcinogens and non-carcinogens using next-generation RNA sequencing, DNA microarray, and qPCR;Genes and Environment;2023-02-09

2. Epigenetics in toxicology and drug development;Medical Epigenetics;2021

3. Rationale and Roadmap for Developing Panels of Hotspot Cancer Driver Gene Mutations as Biomarkers of Cancer Risk;Environmental and Molecular Mutagenesis;2019-10-06

4. Aberrant cell cycle regulation in rat liver cells induced by post-initiation treatment with hepatocarcinogens/hepatocarcinogenic tumor promoters;Experimental and Toxicologic Pathology;2016-08

5. An integrative test strategy for cancer hazard identification;Critical Reviews in Toxicology;2016-05-03